ConductScience.org, home

Paper1707342

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Günthert U and 9 others. Cell, 1991. Cited by 1,645 papers, by iCite.

Cite this record

ConductScience Library. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Papers, record 1707342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1707342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.
PubMed
Journal
Cell
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,645
iCite
Relative citation ratio, by iCite
39
iCite
Revised in PubMed
2022-04-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Günthert UU
2Hofmann MM
3Rudy WW
4Reber SS
5Zöller MM
6Haussmann II
7Matzku SS
8Wenzel AA
9Ponta HH
10Herrlich PP

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasm MetastasisMajor topic
Receptors, Lymphocyte HomingMajor topic
Amino Acid Sequence
Animals
Antibodies, Monoclonal
Antibodies, Neoplasm
Antibody Specificity
Base Sequence
Cloning, Molecular
DNA, Neoplasm
Epitopes
Molecular Sequence Data
RNA, Messenger
RNA, Neoplasm
Rats
Restriction Mapping
Sequence Homology, Nucleic Acid
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by497

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,645 citations.

PMIDTitleJournalYearIn PapersSource
42504052Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy.Cancer Med2026https://conductscience.org/library/papers/42504052PubMed
42353077CD44-Hyaluronan-Dependent Monocyte Rolling.Int J Mol Sci2026https://conductscience.org/library/papers/42353077PubMed
42074287Chemokine-Independent VLA-4/VCAM-1-Mediated Rolling and Arrest of B16 Melanoma Cells Under Shear.Int J Mol Sci2026https://conductscience.org/library/papers/42074287PubMed
42063841Harnessing Membrane-Active Peptides for Selective Cancer Targeting: Phosphatidylserine Recognition by Tilapia Piscidin 4.JACS Au2026https://conductscience.org/library/papers/42063841PubMed
41813784CD44v6 is associated with tumor aggressiveness and chemoresistance in bladder cancer.Sci Rep2026https://conductscience.org/library/papers/41813784PubMed
41537901Next-generation CAR-T therapy for acute myeloid leukemia: bridging innovation with clinical translation.Ann Hematol2026https://conductscience.org/library/papers/41537901PubMed
41367861CD44 targeted functionalized nanocarriers for non-small cell lung cancer.Front Oncol2025https://conductscience.org/library/papers/41367861PubMed
40646591Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer.Cancer Cell Int2025https://conductscience.org/library/papers/40646591PubMed
40335696Activation of lysosomal iron triggers ferroptosis in cancer.Nature2025https://conductscience.org/library/papers/40335696PubMed
40205882The progress of hyaluronic acid's application in therapeutic delivery.Ther Deliv2025https://conductscience.org/library/papers/40205882PubMed
39851489Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy.Cells2025https://conductscience.org/library/papers/39851489PubMed
39273139Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas.Int J Mol Sci2024https://conductscience.org/library/papers/39273139PubMed
38826119Targeting the core program of metastasis with a novel drug combination.Cancer Med2024https://conductscience.org/library/papers/38826119PubMed
38790166CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation.Genes (Basel)2024https://conductscience.org/library/papers/38790166PubMed
38672650CD44: A New Prognostic Marker in Colorectal Cancer?Cancers (Basel)2024https://conductscience.org/library/papers/38672650PubMed
38478335Surface Markers for the Identification of Cancer Stem Cells.Methods Mol Biol2024https://conductscience.org/library/papers/38478335PubMed
38039408Osteopontin induces mitochondrial biogenesis in deadherent cancer cells.Oncotarget2023https://conductscience.org/library/papers/38039408PubMed
37832027Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion.Blood2023https://conductscience.org/library/papers/37832027PubMed
37489367Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C44Mab-94 against Gastric Carcinomas.Antibodies (Basel)2023https://conductscience.org/library/papers/37489367PubMed
37452042Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis.Cell Death Dis2023https://conductscience.org/library/papers/37452042PubMed

See all 497 cited byDownload CSV of cited by

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKM61874GENBANK
GENBANKM61875GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1707342

GET https://conductscience.org/api/papers/v1/1707342/cited_by?page=2